ORLANDO--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced results from a 52-week Phase 3b study in adults with type 2 diabetes who had inadequate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback